Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Peritoneal Neoplasms × Cisplatin × Clear all

Phase

Phase 2 9 Phase 1 5 Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 43 Squamous Cell Carcinoma of Head and Neck 17 Lung Neoplasms 17 Head and Neck Neoplasms 14 Neoplasms 12 Stomach Neoplasms 11 Urinary Bladder Neoplasms 10 Ovarian Neoplasms 10 Esophageal Neoplasms 10 Uterine Cervical Neoplasms 9 Small Cell Lung Carcinoma 9 Pancreatic Neoplasms 9 Colorectal Neoplasms 9 Biliary Tract Neoplasms 9 Triple Negative Breast Neoplasms 7 Neoplasm Metastasis 6 Mesothelioma, Malignant 6 Melanoma 6 Carcinoma, Transitional Cell 6 Breast Neoplasms 6 Recurrence 5 Nasopharyngeal Carcinoma 5 Esophageal Squamous Cell Carcinoma 5 Cholangiocarcinoma 4 Carcinoma, Small Cell 4 Adenocarcinoma Of Esophagus 4 Radiation Injuries 3 Oropharyngeal Neoplasms 3 Nasopharyngeal Neoplasms 3 Mesothelioma 3

Interventions

tremelimumab 1 poly(I).poly(c12,U) 1 olaparib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 genexol-PM 1 abagovomab 1 Paclitaxel 1 Oxaliplatin 1 MOC31PE immunotoxin 1 Introns 1 Interferon alpha-2 1 Hyperthermic Intraperitoneal Chemotherapy 1 Drug Therapy 1 Doxorubicin 1 Cytoreduction Surgical Procedures 1 Cisplatin 1 Celecoxib 1 Bevacizumab 1 AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase 1 Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02604784 2020-09-17

PI-CaP

Fondazione del Piemonte per l'Oncologia

Phase 1/2 Completed

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡